{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:36:25Z","timestamp":1791894985230,"version":"4.3.4"},"reference-count":94,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Human immunodeficiency virus (HIV), comprising two distinct types, HIV-1 and HIV-2, remains one of the most significant global health challenges, originating from multiple cross-species transmissions of simian immunodeficiency viruses (SIVs) in the early 20th century. This review traces the evolutionary trajectory of HIV from zoonotic spillover to its establishment as a global pandemic. HIV-1, the principal strain responsible for AIDS, emerged from SIVcpz in Central African chimpanzees, with phylogenetic evidence indicating initial human transmission between the 1920s and 1940s in present day Democratic Republic of Congo. The virus disseminated through colonial trade networks, reaching the Caribbean by the 1960s before establishing endemic transmission in North America and Europe. HIV\u2019s extraordinary genetic diversity\u2014driven by high mutation rates (~10\u22125 mutations per base per replication cycle) and frequent recombination events\u2014has generated multiple groups, subtypes, and circulating recombinant forms (CRFs) with distinct epidemiological patterns. HIV-1 Group M, comprising subtypes A through L, accounts for over 95% of global infections, with subtype C predominating in sub-Saharan Africa and Asia, while subtype B dominates in Western Europe and North America. The extensive genetic heterogeneity of HIV significantly impacts diagnostic accuracy, antiretroviral therapy efficacy, and vaccine development, as subtypes exhibit differential biological properties, transmission efficiencies, and drug resistance profiles. Contemporary advances, including next-generation sequencing (NGS) for surveillance, broadly neutralizing antibodies for cross-subtype prevention and therapy, and long-acting antiretroviral formulations to improve adherence, have transformed HIV management and prevention strategies. NGS enables near real-time surveillance of drug resistance mutations and inference of transmission networks where it is available, although access and routine application remain uneven across regions. Broadly neutralizing antibodies demonstrate cross-subtype efficacy, while long-acting formulations have the potential to improve treatment adherence. This review synthesizes recent evidence and offers actionable recommendations to optimize clinical and public health responses\u2014including the routine use of genotypic resistance testing where feasible, targeted use of phylogenetic analysis for outbreak investigation, and the development of region-specific diagnostic and treatment algorithms informed by local subtype prevalence. While the understanding of HIV\u2019s evolutionary dynamics has substantially improved and remains essential, translating this knowledge into universally implemented intervention strategies remains a key challenge for achieving the UNAIDS 95-95-95 targets and the goal of ending AIDS as a public health threat by 2030.<\/jats:p>","DOI":"10.3390\/ijms262210909","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T08:57:41Z","timestamp":1762851461000},"page":"10909","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The Origins and Genetic Diversity of HIV-1: Evolutionary Insights and Global Health Perspectives"],"prefix":"10.3390","volume":"26","author":[{"given":"Ivailo","family":"Alexiev","sequence":"first","affiliation":[{"name":"National Reference Confirmatory Laboratory of HIV, National Center of Infectious and Parasitic Diseases (NCIPD), 1504 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7711-6798","authenticated-orcid":false,"given":"Reneta","family":"Dimitrova","sequence":"additional","affiliation":[{"name":"National Reference Confirmatory Laboratory of HIV, National Center of Infectious and Parasitic Diseases (NCIPD), 1504 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"ref_1","unstructured":"(2025, November 08). UNAIDS Global HIV & AIDS Statistics\u2014Fact Sheet. Available online: https:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1038\/s41467-020-19801-x","article-title":"Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase","volume":"11","author":"Siedner","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"100912","DOI":"10.1016\/S2666-5247(24)00151-4","article-title":"Global and regional genetic diversity of HIV-1 in 2010\u201321: Systematic review and analysis of prevalence","volume":"5","author":"Nair","year":"2024","journal-title":"Lancet Microbe."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/QAD.0000000000002883","article-title":"Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: A multivariable analysis","volume":"35","author":"Cutrell","year":"2021","journal-title":"AIDS"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1126\/science.6981847","article-title":"A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia","volume":"218","author":"Kalyanaraman","year":"1982","journal-title":"Science"},{"key":"ref_7","unstructured":"Centers for Disease Control and Prevention (CDC) (1981). Pneumocystis pneumonia\u2014Los Angeles. MMWR Morb. Mortal. Wkly. Rep., 30, 1\u20133."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.6189183","article-title":"Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)","volume":"220","author":"Chermann","year":"1983","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1126\/science.6200936","article-title":"Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS","volume":"224","author":"Gallo","year":"1984","journal-title":"Science"},{"key":"ref_10","unstructured":"World Health Organization (WHO) (2025, September 29). People Who Inject Drugs. Available online: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/populations\/people-who-inject-drugs#:~:text=In%20some%20reions%2C%20such%20as,drugs%20(WHO%2C%202016)."},{"key":"ref_11","unstructured":"UNAIDS (2015). On the Fast-Track to an AIDS-Free Generation, UNAIDS."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.biochem.67.1.1","article-title":"HIV-1: Fifteen proteins and an RNA","volume":"67","author":"Frankel","year":"1998","journal-title":"Annu. Rev. Biochem."},{"key":"ref_13","unstructured":"(2025, September 29). HIV.gov. Acute and Chronic HIV, Available online: https:\/\/www.hiv.gov\/hiv-basics\/overview\/about-hiv-and-aids\/acute-and-chronic-hiv."},{"key":"ref_14","unstructured":"(2025, September 29). HIVinfo.NIH.gov. HIV Overview. HIV and Stages of Infection, Available online: https:\/\/hivinfo.nih.gov\/understanding-hiv\/fact-sheets\/print\/17."},{"key":"ref_15","unstructured":"Centers for Disease Control and Prevention (CDC) (2025, September 29). About HIV, Available online: https:\/\/www.cdc.gov\/hiv\/about\/index.html."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1128\/jvi.69.8.5087-5094.1995","article-title":"Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase","volume":"69","author":"Mansky","year":"1995","journal-title":"J. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrmicro2614","article-title":"Why do RNA viruses recombine?","volume":"9","author":"Holmes","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"a006841","DOI":"10.1101\/cshperspect.a006841","article-title":"Origins of HIV and the AIDS pandemic","volume":"1","author":"Sharp","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_19","first-page":"934","article-title":"Island biogeography reveals the deep history of SIV","volume":"354","author":"Worobey","year":"2010","journal-title":"Science"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1126\/science.287.5453.607","article-title":"AIDS as a zoonosis: Scientific and public health implications","volume":"287","author":"Hahn","year":"2000","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1473-3099(10)70186-9","article-title":"Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease","volume":"11","author":"Tebit","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.1256739","article-title":"HIV epidemiology. The early spread and epidemic ignition of HIV-1 in human populations","volume":"346","author":"Faria","year":"2014","journal-title":"Science"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/17130","article-title":"Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes","volume":"397","author":"Gao","year":"1999","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s11908-007-0052-x","article-title":"The origins of HIV and implications for the global epidemic","volume":"9","author":"Peeters","year":"2007","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10393-017-1229-x","article-title":"A Review of Zoonotic Infection Risks Associated with the Wild Meat Trade in Malaysia","volume":"14","author":"Cantlay","year":"2017","journal-title":"Ecohealth"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1126\/science.1126531","article-title":"Chimpanzee reservoirs of pandemic and nonpandemic HIV-1","volume":"313","author":"Keele","year":"2006","journal-title":"Science"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature07390","article-title":"Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960","volume":"455","author":"Worobey","year":"2008","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/339389a0","article-title":"An African primate lentivirus closely related to HIV-2","volume":"339","author":"Hirsch","year":"1989","journal-title":"Nature"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1126\/science.7915856","article-title":"Reduced rate of disease development after HIV-2 infection as compared to HIV-1","volume":"265","author":"Marlink","year":"1994","journal-title":"Science"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1128\/AAC.00154-09","article-title":"Antiretroviral drug resistance in human immunodeficiency virus type 2","volume":"53","author":"Ntemgwa","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/35400","article-title":"An African HIV-1 sequence from 1959 and implications for the origin of the epidemic","volume":"391","author":"Zhu","year":"1998","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrg1246","article-title":"The causes and consequences of HIV evolution","volume":"5","author":"Rambaut","year":"2004","journal-title":"Nat. Rev. Genet."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Pepin, J. (2011). The Origins of AIDS, Cambridge University Press.","DOI":"10.1017\/CBO9781139005234"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Sousa, J.D., M\u00fcller, V., and Vandamme, A.M. (2022). The Impact of Genital Ulcers on HIV Transmission Has Been Underestimated-A Critical Review. Viruses, 14.","DOI":"10.3390\/v14030538"},{"key":"ref_35","first-page":"522","article-title":"The emergence of HIV\/AIDS in the Americas and beyond","volume":"317","author":"Gilbert","year":"2007","journal-title":"Science"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Junqueira, D.M., de Medeiros, R.M., Matte, M.C., Ara\u00fajo, L.A., Chies, J.A., Ashton-Prolla, P., and Almeida, S.E. (2011). Reviewing the history of HIV-1: Spread of subtype B in the Americas. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0027489"},{"key":"ref_37","unstructured":"UNAIDS (2006). Report on the Global AIDS Epidemic, UNAIDS. Available online: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2006_gr-executivesummary_en_0.pdf."},{"key":"ref_38","first-page":"1","article-title":"The challenge of global health","volume":"73","author":"Garrett","year":"2007","journal-title":"Foreign Aff."},{"key":"ref_39","first-page":"519","article-title":"HIV\/AIDS in women: An expanding epidemic","volume":"266","author":"Quinn","year":"2005","journal-title":"Science"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1126\/science.7824947","article-title":"HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy","volume":"267","author":"Coffin","year":"1995","journal-title":"Science"},{"key":"ref_41","first-page":"315","article-title":"The DNA provirus hypothesis: The basis for a radical change in our thoughts about cancer","volume":"3","author":"Temin","year":"1974","journal-title":"Cell"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"a007096","DOI":"10.1101\/cshperspect.a007096","article-title":"HIV latency","volume":"1","author":"Siliciano","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Ebina, H., Misawa, N., Kanemura, Y., and Koyanagi, Y. (2013). Harnessing the CRISPR\/Cas9 system to disrupt latent HIV-1 provirus. Sci. Rep., 3.","DOI":"10.1038\/srep02510"},{"key":"ref_44","first-page":"1956","article-title":"CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape","volume":"30","author":"Wang","year":"2016","journal-title":"Mol. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1126\/science.2460925","article-title":"The accuracy of reverse transcriptase from HIV-1","volume":"242","author":"Roberts","year":"1988","journal-title":"Science"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMra025195","article-title":"HIV drug resistance","volume":"350","author":"Clavel","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/COH.0b013e32832ea7e8","article-title":"Specificity of the autologous neutralizing antibody response","volume":"4","author":"Moore","year":"2009","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_48","unstructured":"Hemelaar, J., Elangovan, R., Yun, J., Dickson-Dillman, E., Psichogiou, M., Aralaguppe, S.G., Sankaran, V., Phillips, A.N., Vegvari, C., and Ward, M.J. (2020). Global and regional molecular epidemiology of HIV-1, 1990\u20132015: A systematic review, global survey, and trend analysis. Lancet Infect. Dis., 20."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1084\/jem.185.4.621","article-title":"Change in coreceptor use correlates with disease progression in HIV-1-infected individuals","volume":"185","author":"Connor","year":"1997","journal-title":"J. Exp. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1086\/512682","article-title":"HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 RNA loads","volume":"195","author":"Baeten","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/088922200309052","article-title":"Molecular epidemiology of HIV type 1 in a rural community in southwest Uganda","volume":"16","author":"Kaleebu","year":"2000","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1086\/430742","article-title":"Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012","volume":"192","author":"Flys","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1128\/JCM.00119-09","article-title":"Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both conventional and variant forms of HIV","volume":"47","author":"Pandori","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1128\/JVI.74.3.1234-1240.2000","article-title":"High rate of recombination throughout the human immunodeficiency virus type 1 genome","volume":"74","author":"Jetzt","year":"2000","journal-title":"J. Virol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.genet.35.102401.090551","article-title":"Mechanisms of retroviral recombination","volume":"35","author":"Negroni","year":"2001","journal-title":"Annu. Rev. Genet."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.molmed.2011.12.001","article-title":"The origin and diversity of the HIV-1 pandemic","volume":"18","author":"Hemelaar","year":"2012","journal-title":"Trends Mol. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1002\/jmv.20599","article-title":"Global epidemiology of HIV","volume":"78","author":"McCutchan","year":"2006","journal-title":"J. Med. Virol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/infdis\/jiu666","article-title":"Global dispersal pattern of HIV type 1 subtype CRF01_AE: A genetic trace of human mobility related to heterosexual sexual activities centralized in Southeast Asia","volume":"211","author":"Angelis","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"He, X., Xing, H., Ruan, Y., Hong, K., Cheng, C., Hu, Y., Xin, R., Wei, J., Feng, Y., and Hsi, J.H. (2012). A comprehensive mapping of HIV-1 genotypes in various risk groups and regions across China based on a nationwide molecular epidemiologic survey. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0047289"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.288.5463.55d","article-title":"HIV-1 nomenclature proposal","volume":"288","author":"Robertson","year":"2000","journal-title":"Science"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.1128\/JVI.74.22.10498-10507.2000","article-title":"Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa","volume":"74","author":"Vidal","year":"2000","journal-title":"J. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/QAI.0000000000000809","article-title":"Using molecular HIV surveillance data to understand transmission between subpopulations in the United States","volume":"70","author":"Oster","year":"2015","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1097\/01.aids.0000131395.14339.f5","article-title":"Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates","volume":"18","author":"Touloumi","year":"2004","journal-title":"AIDS"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1742-4690-7-22","article-title":"Phylodynamics of HIV-1 circulating recombinant forms 12_BF and 38_BF in Argentina and Uruguay","volume":"7","author":"Bello","year":"2010","journal-title":"Retrovirology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1089\/aid.2006.0300","article-title":"Identification of CRF34_01B, a second circulating recombinant form unrelated to and more complex than CRF15_01B, among injecting drug users in northern Thailand","volume":"23","author":"Tovanabutra","year":"2007","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/S0140-6736(07)61015-0","article-title":"Prevalence of HIV infection in conflict-affected and displaced people in seven sub-Saharan African countries: A systematic review","volume":"369","author":"Spiegel","year":"2007","journal-title":"Lancet"},{"key":"ref_67","unstructured":"UNAIDS (2022). In Danger: UNAIDS Global AIDS Update 2022, UNAIDS."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1046\/j.1365-3156.2003.01110.x","article-title":"Mumbai disease in far western Nepal: HIV infection and syphilis among male migrant-returnees and non-migrants","volume":"8","author":"Poudel","year":"2003","journal-title":"Trop. Med. Int. Health"},{"key":"ref_69","first-page":"2251","article-title":"Transmitted antiretroviral drug resistance among newly HIV-1 diagnosed young individuals in Kampala","volume":"22","author":"Ndembi","year":"2008","journal-title":"AIDS"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Santoro, M.M., and Perno, C.F. (2013). HIV-1 genetic variability and clinical implications. ISRN Microbiol., 2013.","DOI":"10.1155\/2013\/481314"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"10234","DOI":"10.1128\/JVI.72.12.10234-10241.1998","article-title":"An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G, and I)","volume":"72","author":"Gao","year":"1998","journal-title":"J. Virol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/v2020503","article-title":"HIV Genetic Diversity and Drug Resistance","volume":"2","author":"Santos","year":"2010","journal-title":"Viruses"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1128\/JVI.00495-16","article-title":"HIV-1 Protease, Reverse Transcriptase, and Integrase Variation","volume":"90","author":"Rhee","year":"2016","journal-title":"J. Virol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.eclinm.2019.03.006","article-title":"Trends in pretreatment HIV-1 drug resistance in antiretroviral therapy-naive adults in South Africa, 2000\u20132016: A pooled sequence analysis","volume":"9","author":"Chimukangara","year":"2019","journal-title":"EClinicalMedicine"},{"key":"ref_75","unstructured":"World Health Organization (WHO) (2021). HIV Drug Resistance Report 2021, World Health Organization."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0140-6736(18)31364-3","article-title":"Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1\/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)","volume":"392","author":"Barouch","year":"2018","journal-title":"Lancet"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Shim, I., Rogowski, L., and Venketaraman, V. (2025). Progress and Recent Developments in HIV Vaccine Research. Vaccines, 13.","DOI":"10.3390\/vaccines13070690"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1073\/pnas.0911004107","article-title":"Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility","volume":"107","author":"Pancera","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"rgp120 HIV Vaccine Study Group (2005). Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J. Infect. Dis., 191, 654\u2013665.","DOI":"10.1086\/428404"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Adepoju, V.A., Udah, D.C., Onyezue, O.I., Adnani, Q.E.S., Jamil, S., and Bin Ali, M.N. (2025). Navigating the Complexities of HIV Vaccine Development: Lessons from the Mosaico Trial and Next-Generation Development Strategies. Vaccines, 13.","DOI":"10.3390\/vaccines13030274"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/14760584.2019.1675518","article-title":"Aiming for protective T-cell responses: A focus on the first generation conserved-region HIVconsv vaccines","volume":"18","author":"Hanke","year":"2019","journal-title":"Expert Rev. Vaccines"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e00041-24","DOI":"10.1128\/cmr.00041-24","article-title":"mRNA-based HIV-1 vaccines","volume":"37","author":"Ahmed","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/22221751.2020.1713707","article-title":"Broadly neutralizing antibodies for HIV-1: Efficacies, challenges and opportunities","volume":"9","author":"Liu","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.immuni.2020.09.007","article-title":"HIV-1 VRC01 germline-targeting immunogens select distinct epitope-specific B cell receptors","volume":"53","author":"Lin","year":"2020","journal-title":"Immunity"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"eadr8382","DOI":"10.1126\/science.adr8382","article-title":"Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans","volume":"389","author":"Willis","year":"2025","journal-title":"Science"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1056\/NEJMoa1608243","article-title":"Effect of HIV antibody VRC01 on viral rebound after treatment interruption","volume":"375","author":"Bar","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e2308942121","DOI":"10.1073\/pnas.2308942121","article-title":"Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features","volume":"121","author":"Juraska","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/QAD.0000000000001470","article-title":"Defining HIV-1 transmission clusters based on sequence data","volume":"31","author":"Hassan","year":"2017","journal-title":"AIDS"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Faria, N.R., Suchard, M.A., Rambaut, A., Streicker, D.G., and Lemey, P. (2013). Simultaneously reconstructing viral cross-species transmission history and identifying the underlying constraints. Philos. Trans. R. Soc. Lond. B Biol. Sci., 368.","DOI":"10.1098\/rstb.2012.0196"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1016\/S2352-3018(16)00046-1","article-title":"Near real-time monitoring of HIV transmission hotspots from routine HIV genotyping: An implementation case study","volume":"3","author":"Poon","year":"2016","journal-title":"Lancet HIV"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1128\/JVI.02051-08","article-title":"CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: Implications for the epidemic","volume":"83","author":"Abraha","year":"2009","journal-title":"J. Virol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1038\/s41591-024-03277-z","article-title":"Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells","volume":"30","author":"Mamez","year":"2024","journal-title":"Nat. Med."},{"key":"ref_93","unstructured":"B\u00e1rtolo, I., Abecasis, A.B., Borrego, P., Barroso, H., McCutchan, F., Gomes, P., Camacho, R., and Taveira, N. (2009). Origin and epidemiological history of HIV-1 CRF14_BG. PLoS ONE, 4."},{"key":"ref_94","unstructured":"UNAIDS (2021). Global AIDS Update 2021\u2014Confronting Inequalities\u2014Lessons for Pandemic Responses from 40 Years of AIDS, UNAIDS. Available online: https:\/\/www.unaids.org\/en\/resources\/documents\/2021\/2021-global-aids-update."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/22\/10909\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T05:17:57Z","timestamp":1763011077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/22\/10909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":94,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["ijms262210909"],"URL":"https:\/\/doi.org\/10.3390\/ijms262210909","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]}}}